FABP4 and triple-negative breast carcinoma: Serum FABP4 levels are negatively correlated with overall survival in patients[69], and its overexpression promotes lipid uptake via CD36 synergy, activating the STAT3 pathway to induce epithelial-mesenchymal transition (EMT) and stemness in triple-negative breast cancer (TNBC)[69,70].